eyeforpharma

Dr. Bates’ Talkback: Payers and personalized medicine

Andree Bates, (May 18, 2012)

Dr. Andree K. Bates examines the 5 issues that need to be addressed to increase uptake of personalized medicine
Pharma and clinical outsourcing strategies

Mary Wieder, (May 14, 2012)

Mary Wieder of Arithmos suggests some tips on how pharma should assess potential outsourcing partners
Healthcare innovation: Panacea or pitfall?

Pete Gale, (May 11, 2012)

Pete Gale, head of user experience for Blue Latitude, on the challenge of innovation
3 Google innovations and changes pharma needs to know about

Cherie Yates, (May 10, 2012)

Cherie Yates of Siren Interactive examines the Google products and innovations that will affect the paid and organic search strategies of pharma firms

cadelarge, (Apr 16, 2012)

Craig DeLarge examines how pharma can capitalize on yet another new media trend.

Malcolm Allison, (Mar 28, 2012)

Experience matters, wherever you’re from

Though the Internet is not quite a mass medium yet, Brazilians are very open to interacting with brands via social media

Paul Cook, (Mar 28, 2012)

Paul Cook, analytics consultant with Blue Latitude, on the impact of the EU’s privacy directive on digital marketing and sales tracking

Will Myddelton, (Mar 28, 2012)

Will Myddelton, user experience consultant with Blue Latitude, on the human side of behavior change

Pharma sales reps and the e-training alternative

Andrew Tolve, (Apr 26, 2012)

Andrew Tolve examines how virtual sales training can boost selling skills—and save money
Pharma Sales Teams are full of “dead wood”

Craig Sharp, (Apr 25, 2012)

Industry research shows that Sales Teams have "significantly more dead wood in the field forces than in other industries" and that company "best practice" may not actually be what's best for your company...
Pharma sales: How simulation can help reps sell

Andrew Tolve, (Mar 28, 2012)

Andrew Tolve explores how ‘selling simulators’—realistic virtual encounters with physicians—can help reps achieve real sales growth

More Sales

Pharma a leader in web effectiveness

Craig Sharp, (May 14, 2012)

Often criticised for not properly adopting new web technologies, pharma proves it knows a thing or two about the corporate website.
Pharma marketing and social media

Andrew Tolve, (Apr 22, 2012)

Andrew Tolve reports on best practice in deploying social media for pharma marketing
Pharma and direct-to-consumer marketing in Japan

Andrew Tolve, (Apr 12, 2012)

Andrew Tolve explores how Japanese pharma firms are using direct-to-consumer (DTC) marketing campaigns to share health information and create brand awareness

More Marketing

Pharma, adherence, and digital health coaching

Andrew Tolve, (May 2, 2012)

Andrew Tolve explores how digital health coaching is helping the healthcare industry provide cost-effective services that boost adherence
Patients, social games and pharma

Andrew Tolve, (Apr 3, 2012)

Andrew Tolve reports on how pharma can use ‘gamification’ to boost adherence and improve the bottom line
How to predict non-adherence

Andrew Tolve, (Mar 11, 2012)

Andrew Tolve examines new techniques to identify patients likely to be non-adherent before they exhibit the behavior

More Patients

How to build integrated global forecasting teams

Andrew Tolve, (Mar 20, 2012)

Miriam Stache, senior European demand forecasting manager at Eli Lilly, on how integrated teams can provide more reliable forecasts
Forecasting 2.0: How to make forecasting a strategic imperative

Andrew Tolve, (Nov 6, 2011)

Prasad Saraph, business partner at Bayer HealthCare, explains why forecasting must reflect an organization’s collective intelligence
Forecasting the future of biologics

Peter Mansell, (Sep 15, 2011)

Peter Mansell reports on how to balance complexity and predictability when forecasting for biologics

More Forecasting

Market access: Pharma and the definition of value

Editor, (May 8, 2012)

Jan Stojaspal explores the role of value-based pricing in gaining market access
Market access and the need for stakeholder-centricity

Editor, (Apr 10, 2012)

Jan Stojaspal examines how pharma can build mutually advantageous partnerships within a changing stakeholder environment
Pharma and market access: How to overcome the challenges

Peter Mansell, (Feb 20, 2012)

Steven Flostrand, principal at IMS Consulting Group, on how to thrive in pharma’s difficult market environment

More Market Access